Additionally, our results underscore the clinical value of 18F-DCFPyL PET/CT in managing BCR of PC, as it enhances diagnostic accuracy and facilitates the development of personalized treatment strategies, offering both localized and systemic therapeutic options. The gene discussed is BCR; the disease is pachyonychia congenita.